Hopes and failures in front-line advanced HER2-positive gastric cancer therapy : Anti-Cancer Drugs

Journal Logo

Review

Hopes and failures in front-line advanced HER2-positive gastric cancer therapy

Kong, Fanminga,,b,,*; Yao, Yanga,,b,,*; Deng, Renfena,,b; Li, Xiaojianga,,b; Jia, Yingjiea,,b

Author Information
Anti-Cancer Drugs 32(7):p 675-680, August 2021. | DOI: 10.1097/CAD.0000000000001081

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid